Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010) [Phase 2]

View source ↗

Summary

Phase 2 randomized trial of MK-8457 in rheumatoid arthritis was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MK-8457

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2017-02-23